The plaintiff in the second trial over the DePuy Orthopaedics ASR hip implant is seeking punitive damages – indicating “fraud or malice” – as well as compensatory damages, according to Reuters.
The first trial of nearly 11,000 such cases recently concluded in Los Angeles. Although the jury in that case rejected punitive damages, Johnson & Johnson’s DePuy Orthopaedics division must still pay the defendant – a retired prison guard who said ...
continue reading...
Another trial involving a DePuy Orthopaedics hip implant is set to begin in Illinois, right on the heels of a Los Angeles trial that netted an $8.33 million settlement for the plaintiff, Reuters reports.
In all, nearly 11,000 lawsuits have been filed over the ASR hip implant, which Johnson & Johnson subsidiary DePuy Orthopaedics recalled in 2010 because of their high ...
continue reading...
According to a story on Fox News, prosecutors in Greece have filed corruption charges against officials with DePuy Orthopedics, a subsidiary of Johnson & Johnson.
Five unnamed company officials have been charged with money laundering, and paying more than $21.5 million in bribes to Greek doctors, in exchange for the doctors promoting DePuy products.
DePuy is also facing legal trouble in the United States, over charges that the company has engaged in ...
continue reading...
An opinion piece in the New York Times explores an issue that emerged in the course of a trial over DePuy Orthopaedics’ ASR hip implants – doctors who remain silent over harmful medical devices or drugs.
Although experts say doctors have an ethical responsibility to speak out in such cases, they often fail to warn their colleagues, the New York Times reports.
In the case of DePuy Orthopaedics, a subsidiary of Johnson ...
continue reading...
A new study funded by the U.S. Food and Drug Administration reports that artificial hip implants are more likely to prematurely fail and need replacement for female patients, according to a CBS News story.
The story says researchers at Weill Cornell Medical College in New York City analyzed the results for 35,000 hip implant recipients. They found that women were almost 30 percent more likely than men to need a repeat ...
continue reading...An editorial in the Newark Star Ledger titled “Another black eye for J&J” says that Johnson & Johnson’s actions with regards to its ASR hip replacement were not only unethical, but would have landed an individual in prison.
Johnson & Johnson recalled the implants, made by subsidiary DePuy Orthopaedics, in 2010 after studies showed that nearly half of them broke down ...
continue reading...
